Two-drug Immunotherapy May Produce Better Survival in Advanced Melanoma September 22, 2016Vol.39 No.08
Abemaciclib Phase III Trial Continues After Interim Efficacy Criteria Not Met September 22, 2016Vol.39 No.08
Tecentriq Demonstrates Increase In Overall NSCLC Survival in Phase III Study September 22, 2016Vol.39 No.08
Phase III Gazyva Trial Fails to Meet Primary Endpoint of Improving PFS in DLBCL August 04, 2016Vol.39 No.07
Free Five-Year Adcetris Results Show Patients with Long-term Control of Hodgkin Lymphoma August 04, 2016Vol.39 No.07
Trial: Erbitux-FOLFOX Therapy Improves PFS, OS in RAS Wild-Type Colorectal Cancer August 04, 2016Vol.39 No.07
